Ascendis Pharma A/S (ASND) Competitors

Ascendis Pharma A/S (NASDAQ:ASND) and argenx (NASDAQ:ARGX) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, community ranking, analyst recommendations, media sentiment and institutional ownership.

Which has preferable earnings and valuation, ASND or ARGX?

argenx has higher revenue and earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than argenx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ascendis Pharma A/S	$363.64M	28.58	-$409.12M	-$7.10	-24.01
argenx	$2.19B	17.99	-$295.05M	$12.59	51.24

Do analysts prefer ASND or ARGX?

Ascendis Pharma A/S presently has a consensus target price of $204.67, indicating a potential upside of 20.08%. argenx has a consensus target price of $699.28, indicating a potential upside of 8.39%. Given Ascendis Pharma A/S's stronger consensus rating and higher probable upside, research analysts plainly believe Ascendis Pharma A/S is more favorable than argenx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ascendis Pharma A/S	0 Sell rating(s)	1 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.93
argenx	0 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.91

Do institutionals & insiders hold more shares of ASND or ARGX?

60.3% of argenx shares are owned by institutional investors. 40.0% of Ascendis Pharma A/S shares are owned by company insiders. Comparatively, 2.4% of argenx shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Does the MarketBeat Community favor ASND or ARGX?

argenx received 209 more outperform votes than Ascendis Pharma A/S when rated by MarketBeat users. Likewise, 67.38% of users gave argenx an outperform vote while only 66.87% of users gave Ascendis Pharma A/S an outperform vote.

Company	Underperform	Outperform
Ascendis Pharma A/S	Outperform Votes 448 66.87%	Underperform Votes 222 33.13%
argenx	Outperform Votes 657 67.38%	Underperform Votes 318 32.62%

Is ASND or ARGX more profitable?

argenx has a net margin of -2.11% compared to Ascendis Pharma A/S's net margin of -104.54%. Ascendis Pharma A/S's return on equity of 0.00% beat argenx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ascendis Pharma A/S	-104.54%	N/A	-39.23%
argenx	-2.11%	-1.45%	-1.29%

Does the media refer more to ASND or ARGX?

In the previous week, argenx had 8 more articles in the media than Ascendis Pharma A/S. MarketBeat recorded 20 mentions for argenx and 12 mentions for Ascendis Pharma A/S. argenx's average media sentiment score of 1.29 beat Ascendis Pharma A/S's score of 1.26 indicating that argenx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ascendis Pharma A/S	6 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
argenx	14 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, ASND or ARGX?

Ascendis Pharma A/S has a beta of 0.54, meaning that its share price is 46% less volatile than the S&P 500. Comparatively, argenx has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500.

Summary

argenx beats Ascendis Pharma A/S on 13 of the 19 factors compared between the two stocks.